Fulgent Genetics (FLGT) Gross Profit (2015 - 2026)

Fulgent Genetics has disclosed Gross Profit across 12 years of filings, most recently posting $25.7 million for Q2 2026.

• In Q2 2026, Gross Profit fell 25.43% year-over-year to $25.7 million; the TTM figure through Jun 2026 stood at $115.3 million (down 5.06% YoY), while the FY2025 annual figure was $130.9 million, up 22.07% from the prior year.
• Gross Profit came in at $25.7 million for Q2 2026 at Fulgent Genetics, up from $21.5 million in the prior quarter.
• In the past five years, Gross Profit ranged from a high of $242.5 million in Q1 2022 to a low of $13.0 million in Q4 2022.
• Average Gross Profit over 5 years is $42.0 million, with a median of $27.6 million recorded in 2024.
• Year-over-year, Gross Profit slumped 93.15% in 2022 and soared 94.26% in 2023.
• Over 5 years, Gross Profit stood at $13.0 million in 2022, then soared by 94.26% to $25.2 million in 2023, then grew by 26.24% to $31.8 million in 2024, then climbed by 2.3% to $32.6 million in 2025, then fell by 21.19% to $25.7 million in 2026.
• Per Business Quant data, the three most recent Gross Profit figures were $25.7 million in Q2 2026, $21.5 million in Q1 2026, and $32.6 million in Q4 2025.